Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients

Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas

(2014) Liwei Zhang et al.   NATURE GENETICS

Li-Fraumeni syndrome: cancer risk assessment and clinical management

(2014) Kate A. McBride et al.   Nature Reviews Clinical Oncology

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint

(2013) Petra Kleiblova et al.   JOURNAL OF CELL BIOLOGY

PPM1D Mutations in Circulating White Blood Cells and the Risk for Ovarian Cancer

(2013) Mohammad R. Akbari et al.   JNCI-Journal of the National Cancer Institute

Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol

(2013) Artur Zajkowicz et al.   MOLECULAR BIOLOGY REPORTS

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

(2012) Elise Ruark et al.   NATURE

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL